The Quebec government has the intention to prohibit all accessory fees in health care. (La Presse)
By Fergus Grieve, McGill Newsroom
Depression, metabolic factors combine to boost risk of developing diabetes, study finds
Depression may compound the risk of developing type 2 diabetes in people with early warning signs of metabolic disease, according to researchers from McGill University, l'Université de Montréal, the Institut de recherches cliniques de Montréal and the University of Calgary.
Policy experts advocate mutual recognition for reviews of data-intensive international research
Genomic research holds great potential to advance human health and medicine. But for the millions of data points now being collected through large-scale sequencing efforts to be truly valuable, they must be analyzed in aggregate and shared across institutions and jurisdictions. This raises many challenges, including navigation of complex ethics-approval processes at multiple sites and in multiple jurisdictions.
Secondary Contact Information
Please join us for a special seminar co-hosted by the McGill Institute for Health and Social Policy, the McGill Research Group on Health and Law and the
By Tod Hoffman, Lady Davis Institute for Medical Research
The use of incretin-based drugs is not associated with an increased risk of pancreatic cancer in patients with type 2 diabetes, according to a study published in the latest issue of the British Medical Journal (BMJ).
The research was conducted by the Canadian Network for Observational Drug Effect Studies (CNODES), which used the health records of almost 1 million patients with types 2 diabetes.
By Julie Robert, McGill University Health Centre
A research team, led by the Research Institute of the McGill University Health Centre (RI-MUHC) in Montreal, has broken new ground in our understanding of the complex functioning of the brain.
By Katherine Gombay, McGill Newsroom
If you’re fat, can you blame it on your genes? The answer is a qualified yes. Maybe. Under certain circumstances. Researchers are moving towards a better understanding of some of the roots of obesity.
University of Toronto and McGill University scientists are leading an international partnership to discover new and improved drug treatments for tuberculosis, malaria and neglected tropical diseases -- thanks to a contribution from Merck Canada Inc., as well as an additional $5 million supplement to a grant from the Bill & Melinda Gates Foundation. The new funding brings the total investment from the Bill & Melinda Gates Foundation to nearly US $12 million since 2012.
Secondary Contact Information
A conversation with Dr. Lora Giangregorio, winner of the 2015 Bloomberg Manulife Prize for the Promotion of Active Health
ARE YOU FIT TO THE BONE?
A conversation with Dr. Lora Giangregorio, winner of the Faculty of Education’s 2015 Bloomberg Manulife Prize for the Promotion of Active Health.
The IHSP is happy to present this seminar by Joy Knoblauch, Assistant Professor of Architecture at the University of Michigan and Visiting Research Chair in Philosophy and Public Health. Dr.